TI
CPHI icon

tru Independence’s China Pharma Holdings CPHI Stock Holding History

tru Independence’s Portfolio CPHI Stock Details CPHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-25
Closed -$8 – 429
2020
Q2 		$8 Buy
+25
New +$6.17K ﹤0.01% 627

Other funds holding CPHI

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

tru Independence's CPHI Position: Q3 2020 in Review

tru Independence sold out of China Pharma Holdings (CPHI) in Q3 2020, closing a stake of 25 shares — an estimated $8 sold.

tru Independence first reported a position in CPHI in Q2 2020 and held it in 1 quarter. The position peaked at $8 in Q2 2020. 5 funds tracked by Wall St. Rank hold CPHI as of Q3 2020.

  • tru Independence reported no remaining China Pharma Holdings position as of Q3 2020 after selling out during the quarter.
  • tru Independence sold 25 China Pharma Holdings shares in Q3 2020, an estimated $8.
  • tru Independence first reported a position in China Pharma Holdings in Q2 2020 and held it in 1 quarter.
  • tru Independence's China Pharma Holdings position peaked at $8 in Q2 2020.
  • 5 funds tracked by Wall St. Rank held China Pharma Holdings as of Q3 2020.

Based on tru Independence's 13F filing for Q3 2020, filed 19 Nov 2020.